This grant funds innovative pilot research to advance the understanding, mechanisms, or treatment of all forms of ataxia, supporting both translational and foundational studies.
Funder: National Ataxia Foundation
Due Dates (Anticipated): August 2026: Letter of Intent deadline (projected) | December 2026: Full application deadline (by invitation) (projected)
Funding Amounts: Up to $50,000 for one year; direct research expenses only; no indirect costs allowed.
Summary: Supports innovative, early-phase or pilot research advancing understanding, treatment, or foundational knowledge of hereditary, sporadic, and acquired ataxias.
This grant provides seed funding for new and innovative studies that advance understanding of the cause, pathogenesis, or treatment of hereditary, sporadic, and acquired ataxias. It is designed to assist established investigators in launching early or pilot projects, or to supplement ongoing innovative research with a critical need. The goal is to generate preliminary data that can support applications for larger grants from other sources. The National Ataxia Foundation (NAF) prioritizes both translational research for well-characterized forms of ataxia and foundational studies for rare or less understood forms, aiming to improve outcomes for all individuals affected by ataxia.